San Francisco, United States
Yosemite partners with leading researchers and innovative entrepreneurs working to make cancer non-lethal within our lifetime. The firm deploys capital from early non-profit grantees through late-stage companies to fund advancements across the oncology ecosystem.
13
Total Investments
12
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About Yosemite
Recent Investments (13)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Mar 2026 | |
| Series B | •••••• | Dec 2025 | |
| Series A | •••••• | Nov 2025 | |
| Series A | •••••• | Aug 2025 | |
| Series B | •••••• | Jan 2025 | |
•••• ••••
|
Series B | •••••• | Jan 2024 |
|
•••• ••••
|
Seed Round | •••••• | Nov 2023 |
|
•••• ••••
|
Seed Round | •••••• | Apr 2021 |
|
•••• ••••
|
Seed Round | •••••• | Aug 2020 |
|
•••• ••••
|
Venture Round | •••••• | Jul 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
